L. Kamen

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

R. Lipton, P. Goadsby, V. Coric, 2020, The Lancet.

Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women

V. Coric, R. Bertz, Jennifer Madonia, 2022, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.

R. Findling, R. Mcquade, R. Mankoski, 2011, The Journal of clinical psychiatry.

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

R. Mcquade, G. Manos, M. Aman, 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.

R. Mcquade, R. Mankoski, G. Manos, 2011, Journal of child and adolescent psychopharmacology.